Pancreatic β cell regeneration induced by clinical and preclinical agents

Pancreatic β cell regeneration induced by clinical and preclinical agents

Generation of pancreatic β cells for treatment of diabetes: advances and challenges, Stem Cell Research & Therapy

Paris polyphylla Sm. extract enriched with diosgenin as an antidiabetic agent: In vitro and in vivo study - ScienceDirect

Glucagon-receptor-antagonism-mediated β-cell regeneration as an effective anti-diabetic therapy - ScienceDirect

β cell replacement from human pluripotent stem cell sources. Currently

Organoids — Preclinical Models of Human Disease

PDF) A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis

Flow Cytometry Analysis Showed Heterogeneous Pattern of HNF1b and SOX9

Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges, Stem Cell Research & Therapy

Frontiers Carbon Monoxide in Pancreatic Islet Transplantation: A New Therapeutic Alternative to Patients With Severe Type 1 Diabetes Mellitus

S AL inhibits Notch1 pathway in islets of OLETF rats. (A)

Frontiers T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes

Extracellular vesicles from induced pluripotent stem cell-derived mesenchymal stem cells enhance the recovery of acute kidney injury - Cytotherapy

Relative gene expression and glucose-stimulated insulin secretion after

PDF) A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis

Frontiers Debates in Pancreatic Beta Cell Biology: Proliferation Versus Progenitor Differentiation and Transdifferentiation in Restoring β Cell Mass